Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | EGFR(V)-EDV-Dox |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
EGFR(V)-EDV-Dox is a formulation of EGFR bispecific antibodies coupled with nanocellular compounds containing therapeutic dose of doxorubicin, which delivers the cytotoxic doxorubicin to tumor cells over expressing EGFR, leading to anti-tumor activities (PMID: 26279503). |
| DrugClasses | EGFR Antibody 73 |
| CAS Registry Number | NA |
| NCIT ID | C128897 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| EGFR(V)-EDV-Dox | EGFR(V)-EDV-Dox | 0 | 1 |